Scimeca JC - Search Results

1

Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets.

Schmid-Alliana A, Schmid-Antomarchi H, Al-Sahlanee R, Lagadec P, Scimeca JC, Verron E. Schmid-Alliana A, et al. Among authors: scimeca jc. Int J Mol Sci. 2018 Jan 4;19(1):148. doi: 10.3390/ijms19010148. Int J Mol Sci. 2018. PMID: 29300334 Free PMC article. Review.

2

Gallium modulates osteoclastic bone resorption in vitro without affecting osteoblasts.

Verron E, Masson M, Khoshniat S, Duplomb L, Wittrant Y, Baud'huin M, Badran Z, Bujoli B, Janvier P, Scimeca JC, Bouler JM, Guicheux J. Verron E, et al. Among authors: scimeca jc. Br J Pharmacol. 2010 Apr;159(8):1681-92. doi: 10.1111/j.1476-5381.2010.00665.x. Br J Pharmacol. 2010. PMID: 20397300 Free PMC article.

3

Monocytes differentiation upon treatment with a peptide corresponding to the C-terminus of activated T cell-expressed Tirc7 protein.

Mouline CC, Beranger GE, Schmid-Antomarchi H, Quincey D, Momier D, Boukhechba F, Carle GF, Rochet N, Scimeca JC. Mouline CC, et al. Among authors: scimeca jc. J Cell Physiol. 2012 Aug;227(8):3088-98. doi: 10.1002/jcp.23059. J Cell Physiol. 2012. PMID: 22015593

4

Molecular effects of gallium on osteoclastic differentiation of mouse and human monocytes.

Verron E, Loubat A, Carle GF, Vignes-Colombeix C, Strazic I, Guicheux J, Rochet N, Bouler JM, Scimeca JC. Verron E, et al. Among authors: scimeca jc. Biochem Pharmacol. 2012 Mar 1;83(5):671-9. doi: 10.1016/j.bcp.2011.12.015. Epub 2011 Dec 19. Biochem Pharmacol. 2012. PMID: 22202439

5

Gallium as a potential candidate for treatment of osteoporosis.

Verron E, Bouler JM, Scimeca JC. Verron E, et al. Among authors: scimeca jc. Drug Discov Today. 2012 Oct;17(19-20):1127-32. doi: 10.1016/j.drudis.2012.06.007. Epub 2012 Jun 16. Drug Discov Today. 2012. PMID: 22710367 Review.

6

Therapeutic strategies for treating osteolytic bone metastases.

Verron E, Schmid-Antomarchi H, Pascal-Mousselard H, Schmid-Alliana A, Scimeca JC, Bouler JM. Verron E, et al. Among authors: scimeca jc. Drug Discov Today. 2014 Sep;19(9):1419-26. doi: 10.1016/j.drudis.2014.04.004. Epub 2014 Apr 14. Drug Discov Today. 2014. PMID: 24742971 Review.

7

Adaptive immune response inhibits ectopic mature bone formation induced by BMSCs/BCP/plasma composite in immune-competent mice.

Bouvet-Gerbettaz S, Boukhechba F, Balaguer T, Schmid-Antomarchi H, Michiels JF, Scimeca JC, Rochet N. Bouvet-Gerbettaz S, et al. Among authors: scimeca jc. Tissue Eng Part A. 2014 Nov;20(21-22):2950-62. doi: 10.1089/ten.TEA.2013.0633. Epub 2014 Jun 12. Tissue Eng Part A. 2014. PMID: 24785826

8

Gallium, a promising candidate to disrupt the vicious cycle driving osteolytic metastases.

Strazic-Geljic I, Guberovic I, Didak B, Schmid-Antomarchi H, Schmid-Alliana A, Boukhechba F, Bouler JM, Scimeca JC, Verron E. Strazic-Geljic I, et al. Among authors: scimeca jc. Biochem Pharmacol. 2016 Sep 15;116:11-21. doi: 10.1016/j.bcp.2016.06.020. Epub 2016 Jul 1. Biochem Pharmacol. 2016. PMID: 27378505

9

Gallium enhances reconstructive properties of a calcium phosphate bone biomaterial.

Strazic Geljic I, Melis N, Boukhechba F, Schaub S, Mellier C, Janvier P, Laugier JP, Bouler JM, Verron E, Scimeca JC. Strazic Geljic I, et al. Among authors: scimeca jc. J Tissue Eng Regen Med. 2018 Feb;12(2):e854-e866. doi: 10.1002/term.2396. Epub 2017 May 23. J Tissue Eng Regen Med. 2018. PMID: 28079305

10

The multiple therapeutic applications of miRNAs for bone regenerative medicine.

Scimeca JC, Verron E. Scimeca JC, et al. Drug Discov Today. 2017 Jul;22(7):1084-1091. doi: 10.1016/j.drudis.2017.04.007. Epub 2017 Apr 20. Drug Discov Today. 2017. PMID: 28435060 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page